Close Menu
Home » Intermountain to Roll Out Germline Testing for All Newly Diagnosed Cancer Patients in 2019

Intermountain to Roll Out Germline Testing for All Newly Diagnosed Cancer Patients in 2019

Nov 21, 2018
|
Turna Ray
Premium

NEW YORK (GenomeWeb) – Intermountain Healthcare is planning to test all newly diagnosed cancer patients for mutations in genes that increase their and their families' risks for the disease.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

From the Depths

Researchers have sequenced the genome of the depth-dwelling giant squid.

Not the Research Topic

Prosecutors have charged a former Drexel University professor with theft for allegedly spending federal grant money on adult entertainment and other unrelated expenses, according to the Philadelphia Inquirer.

 

Prison in Insider Trading Case

Chris Collins, a former US representative, has been sentenced to more than two years in prison in an insider trading case involving an Australian biotechnology firm, the New York Times reports.

PNAS Papers on Trypanosoma brucei Transcripts, Inherited Retinal Disease, Gut Microbiome Development

In PNAS this week: Trypanosoma brucei transcripts, estimate of people at risk of inherited retinal disease, and more.

Jan
28
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Feb
05
Featured Webinar

Development of a Novel Multiplex Assay: A Partnership Case Study

Sponsored by
LGC

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.

Feb
20
Featured Webinar

Advances in NGS Gene Expression Studies to Reduce The Cost of Sequencing

Sponsored by
Thermo Fisher Scientific

This webinar will discuss the use of 3’ mRNA sequencing to reduce the cost of gene expression studies on Illumina NGS systems.

Feb
26
Featured Webinar

Transformation of the Lab to Fight Genetic Illnesses in the Amish and Mennonite Populations

Sponsored by
Autogen

This webinar will explain how the Clinic for Special Children in Strasburg, Pennsylvania, has transformed its DNA workflows to improve the diagnosis and treatment of genetic illnesses that are prevalent in the pediatric population of its community.

What's Popular?

In Sequencing

  1. Illumina Targets Single-Cell, Oncology Applications With New NextSeq Platform

    Premium

  2. JP Morgan Healthcare Day 2: 10x Genomics, GenapSys, Caris, Adaptive Bio, Danaher, Agilent, Luminex

  3. Young Bone Marrow Donors May Transfer Pathogenic Mutations to Cancer Patients

  4. Adaptive Biotechnologies Announces Preliminary FY19 Revenue Increase, $257M Stock Offering

  5. FNIH Team Selects Cancer Biomarkers in Phase I of Liquid Biopsy Reference Standards Project

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.